Company Profile

Aptimmune Biologics Inc
Profile last edited on: 1/29/2024      CAGE: 63Y75      UEI: S7N6W8FTTD39

Business Identifier: Prophylactic measures against viral diseases of swine
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

60 Hazelwood Drive
Champaign, IL 61820
   (217) 377-8866
Location: Single
Congr. District: 13
County: Champaign

Public Profile

Aptimmune Biologics specializes in the development and application of prophylactic measures against viral diseases of swine. Their current focus is bringing into the market effective prophylaxis against Porcine Reproductive and Respiratory Syndrome (PRRS) virus. Aptimmune utilizes novel technologies to create effective vaccines against PRRSV such as the proprietary pig alveolar macrophage cell line ZMAC.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Less than .5M
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Aaron Gilbertie -- CEO

  Federico Zuckermann -- Chief Scientific Officer and Founder

  Gabriela Calzada-Nova -- Senior Scientist

  Gary Durack -- Director of Operations